Skip to main content
US EQUITIES PRE-MARKET CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
IH

IHEETF / FundiShares U.S. Pharmaceuticals ETF

$107.05
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment IHE's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 83% of portfolio weight covered
Fund look-through

iShares U.S. Pharmaceuticals ETF ETF · iShares Trust

59 holdings · as of 2026-06-30 (4.7 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.

This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 106% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.

NON-COMPLIANT 30.00% of portfolio weight is in non-compliant holdings, over the 5% threshold.

59 holdings, 39 matched (83% of weight). Portfolio as of 2026-06-30, filed 2026-08-24. Source: SEC Form N-PORT.

1.99% of this portfolio’s income is non-permissible — weighted across holdings, computed over 61% of portfolio weight (36 of 59 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

54.3% compliant 0.0% questionable 28.2% non-compliant 17.5% unscreened

All holdings (59)
HoldingStatusWeightEvery methodology, and the debt ratio behind it
JNJ JOHNSON & JOHNSON COMPLIANT 22.44% AAOIFI6.6% Usmani22.6% Dow Jones Islamic9.3% S&P Shariah10.2% MSCI Islamic22.6% MSCI Islamic M-Series10.2% FTSE Shariah22.6%
LLY ELI LILLY AND COMPANY COMPLIANT 22.25% AAOIFI3.7% Usmani33.4% Dow Jones Islamic5.6% S&P Shariah5.9% MSCI Islamic33.4% MSCI Islamic M-Series5.9% FTSE Shariah33.4%
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares UNSCREENED 6.24% no in-house ratios for this holding
MRK MERCK & CO., INC. COMPLIANT 4.55% AAOIFI15.2% Usmani40.5% Dow Jones Islamic21.0% S&P Shariah20.4% MSCI Islamic40.5% MSCI Islamic M-Series20.4% FTSE Shariah40.5%
BMY BRISTOL-MYERS SQUIBB COMPANY NON_COMPLIANT 4.37% AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9%
RPRX ROYALTY PHARMA PLC NON_COMPLIANT 4.33% AAOIFI21.8% Usmani44.1% Dow Jones Islamic53.0% S&P Shariah60.4% MSCI Islamic44.1% MSCI Islamic M-Series60.4% FTSE Shariah44.1%
VTRS VIATRIS INC. NON_COMPLIANT 4.22% AAOIFI62.1% Usmani39.2% Dow Jones Islamic94.1% S&P Shariah99.0% MSCI Islamic39.2% MSCI Islamic M-Series99.0% FTSE Shariah38.4%
PFE PFIZER INC. NON_COMPLIANT 3.96% AAOIFI38.6% Usmani30.6% Dow Jones Islamic45.7% S&P Shariah45.9% MSCI Islamic30.6% MSCI Islamic M-Series45.9% FTSE Shariah30.6%
ZTS ZOETIS INC. NON_COMPLIANT 3.73% AAOIFI28.0% Usmani61.2% Dow Jones Islamic16.9% S&P Shariah14.7% MSCI Islamic61.2% MSCI Islamic M-Series14.7% FTSE Shariah60.0%
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY UNSCREENED 3.45% no in-house ratios for this holding
ELAN ELANCO ANIMAL HEALTH INCORPORATED NON_COMPLIANT 2.81% AAOIFI26.7% Usmani26.4% Dow Jones Islamic37.4% S&P Shariah40.5% MSCI Islamic26.4% MSCI Islamic M-Series40.5% FTSE Shariah26.4%
AXSM AXSOME THERAPEUTICS, INC. COMPLIANT 2.41% AAOIFI2.9% Usmani27.1% Dow Jones Islamic2.8% S&P Shariah3.3% MSCI Islamic25.3% MSCI Islamic M-Series3.3% FTSE Shariah22.7%
CORT CORCEPT THERAPEUTICS INCORPORATED COMPLIANT 1.90% AAOIFI0.1% Usmani0.9% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.9% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
LGND LIGAND PHARMACEUTICALS INCORPORATED COMPLIANT 1.45% AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5%
Definium Therapeutics Inc UNSCREENED 1.39% no in-house ratios for this holding
LQDA Liquidia Corp COMPLIANT 1.28% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
INDIVIOR PHARMACEUTICALS, INC. UNSCREENED 1.14% no in-house ratios for this holding
Crinetics Pharmaceuticals Inc UNSCREENED 0.90% no in-house ratios for this holding
OGN ORGANON & CO. NON_COMPLIANT 0.81% AAOIFI234.3% Usmani63.8% Dow Jones Islamic292.0% S&P Shariah251.6% MSCI Islamic63.8% MSCI Islamic M-Series251.6% FTSE Shariah63.8%
Edgewise Therapeutics Inc UNSCREENED 0.70% no in-house ratios for this holding
AMRX AMNEAL PHARMACEUTICALS, INC. NON_COMPLIANT 0.68% AAOIFI39.5% Usmani57.1% Dow Jones Islamic77.5% S&P Shariah96.5% MSCI Islamic55.8% MSCI Islamic M-Series96.5% FTSE Shariah55.8%
Enliven Therapeutics Inc UNSCREENED 0.63% no in-house ratios for this holding
SUPERNUS PHARMACEUTICALS, INC. UNSCREENED 0.62% no in-house ratios for this holding
TARS Tarsus Pharmaceuticals Inc COMPLIANT 0.57% AAOIFI2.3% Usmani17.7% Dow Jones Islamic3.5% S&P Shariah4.3% MSCI Islamic17.7% MSCI Islamic M-Series4.3% FTSE Shariah14.4%
Veradermics Inc UNSCREENED 0.56% no in-house ratios for this holding
Alumis Inc UNSCREENED 0.55% no in-house ratios for this holding
NKTR NEKTAR THERAPEUTICS NON_COMPLIANT 0.54% AAOIFI6.0% Usmani7.1% Dow Jones Islamic6.7% S&P Shariah9.2% MSCI Islamic7.1% MSCI Islamic M-Series9.2% FTSE Shariah0.0%
PBH PRESTIGE CONSUMER HEALTHCARE INC. NON_COMPLIANT 0.51% AAOIFI92.5% Usmani45.2% Dow Jones Islamic66.2% S&P Shariah65.0% MSCI Islamic44.8% MSCI Islamic M-Series65.0% FTSE Shariah44.3%
Trevi Therapeutics Inc UNSCREENED 0.50% no in-house ratios for this holding
OCUL OCULAR THERAPEUTIX, INC. NON_COMPLIANT 0.39% AAOIFI0.5% Usmani1.1% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.1% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
INVA INNOVIVA, INC. NON_COMPLIANT 0.36% AAOIFI20.5% Usmani17.5% Dow Jones Islamic19.4% S&P Shariah21.1% MSCI Islamic17.5% MSCI Islamic M-Series21.1% FTSE Shariah16.8%
Amylyx Pharmaceuticals Inc UNSCREENED 0.35% no in-house ratios for this holding
ANIP ANI PHARMACEUTICALS, INC. NON_COMPLIANT 0.34% AAOIFI18.3% Usmani19.0% Dow Jones Islamic16.5% S&P Shariah17.6% MSCI Islamic19.0% MSCI Islamic M-Series17.6% FTSE Shariah19.0%
MBX Biosciences Inc UNSCREENED 0.34% no in-house ratios for this holding
HRMY HARMONY BIOSCIENCES HOLDINGS, INC. NON_COMPLIANT 0.33% AAOIFI8.0% Usmani10.5% Dow Jones Islamic7.9% S&P Shariah8.0% MSCI Islamic10.5% MSCI Islamic M-Series8.0% FTSE Shariah10.1%
PERRIGO COMPANY PUBLIC LIMITED COMPANY UNSCREENED 0.33% no in-house ratios for this holding
HROW HARROW, INC. COMPLIANT 0.32% AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
NUVB NUVATION BIO INC. NON_COMPLIANT 0.32% AAOIFI21.7% Usmani38.6% Dow Jones Islamic20.6% S&P Shariah25.7% MSCI Islamic38.6% MSCI Islamic M-Series25.7% FTSE Shariah36.7%
XERS XERIS BIOPHARMA HOLDINGS, INC. COMPLIANT 0.31% AAOIFI14.8% Usmani68.5% Dow Jones Islamic26.2% S&P Shariah33.9% MSCI Islamic68.5% MSCI Islamic M-Series33.9% FTSE Shariah59.9%
Rapport Therapeutics Inc UNSCREENED 0.27% no in-house ratios for this holding
COLL Collegium Pharmaceutical, Inc. NON_COMPLIANT 0.27% AAOIFI30.8% Usmani11.7% Dow Jones Islamic22.9% S&P Shariah22.6% MSCI Islamic11.7% MSCI Islamic M-Series22.6% FTSE Shariah11.4%
EYPT EYEPOINT, INC. NON_COMPLIANT 0.26% AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
ATAI AtaiBeckley Inc NON_COMPLIANT 0.23% AAOIFI0.9% Usmani9.4% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic9.4% MSCI Islamic M-Series2.5% FTSE Shariah8.7%
PCRX PACIRA BIOSCIENCES, INC. UNRATED 0.23% AAOIFI23.3% Usmani28.3% Dow Jones Islamic32.3% S&P Shariah31.3% MSCI Islamic28.3% MSCI Islamic M-Series31.3% FTSE Shariah24.4%
WVE WAVE Life Sciences Ltd NON_COMPLIANT 0.20% AAOIFI6.1% Usmani8.5% Dow Jones Islamic3.0% S&P Shariah3.5% MSCI Islamic8.5% MSCI Islamic M-Series3.5% FTSE Shariah0.0%
MAZE Maze Therapeutics Inc COMPLIANT 0.19% AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6%
LBRX LB Pharmaceuticals Inc NON_COMPLIANT 0.18% AAOIFI0.4% Usmani1.1% Dow Jones Islamic— S&P Shariah— MSCI Islamic1.1% MSCI Islamic M-Series— FTSE Shariah0.0%
BIOA BIOAGE Labs Inc NON_COMPLIANT 0.18% AAOIFI1.1% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic0.7% MSCI Islamic M-Series— FTSE Shariah0.0%
SEPN Septerna Inc NON_COMPLIANT 0.18% AAOIFI1.2% Usmani3.6% Dow Jones Islamic2.1% S&P Shariahfail MSCI Islamic3.6% MSCI Islamic M-Seriesfail FTSE Shariah0.0%
AMPH AMPHASTAR PHARMACEUTICALS, INC. NON_COMPLIANT 0.16% AAOIFI55.2% Usmani40.4% Dow Jones Islamic57.2% S&P Shariah43.9% MSCI Islamic40.4% MSCI Islamic M-Series43.9% FTSE Shariah35.8%
OMEROS CORPORATION UNSCREENED 0.16% no in-house ratios for this holding
PAHC PHIBRO ANIMAL HEALTH CORPORATION NON_COMPLIANT 0.15% AAOIFI46.9% Usmani43.9% Dow Jones Islamic48.5% S&P Shariah59.2% MSCI Islamic43.9% MSCI Islamic M-Series59.2% FTSE Shariah40.3%
THERAVANCE BIOPHARMA, INC. UNSCREENED 0.15% no in-house ratios for this holding
CRMD CORMEDIX INC. NON_COMPLIANT 0.13% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
PHAT PHATHOM PHARMACEUTICALS, INC. NON_COMPLIANT 0.13% AAOIFI37.6% Usmani48.7% Dow Jones Islamic23.5% S&P Shariah24.1% MSCI Islamic48.7% MSCI Islamic M-Series24.1% FTSE Shariah48.0%
ARVN Arvinas Inc NON_COMPLIANT 0.12% AAOIFI1.7% Usmani1.3% Dow Jones Islamic1.0% S&P Shariah0.6% MSCI Islamic1.3% MSCI Islamic M-Series0.6% FTSE Shariah0.1%
EOLS Evolus Inc NON_COMPLIANT 0.10% AAOIFI37.7% Usmani58.3% Dow Jones Islamic31.2% S&P Shariah26.9% MSCI Islamic58.3% MSCI Islamic M-Series26.9% FTSE Shariah55.3%
BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares UNSCREENED 0.07% no in-house ratios for this holding
XAV HEALTH CARE SEP26 UNSCREENED 0.00% no in-house ratios for this holding

The published standards disagree about this fund by 38 points of portfolio weight — 67.5% of it passes AAOIFI, 29.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 67.5% ratios fail on 19.0% 19.8% not rated under AAOIFI

40 of 59 listed holdings carry our own per-methodology verdicts (88% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 38 (87% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
BMY BRISTOL-MYERS SQUIBB COMPANY 4.37%
RPRX ROYALTY PHARMA PLC 4.33%
VTRS VIATRIS INC. 4.22%
PFE PFIZER INC. 3.96%
ZTS ZOETIS INC. 3.73%
ELAN ELANCO ANIMAL HEALTH INCORPORATED 2.81%
OGN ORGANON & CO. 0.81%
AMRX AMNEAL PHARMACEUTICALS, INC. 0.68%
NKTR NEKTAR THERAPEUTICS 0.54%
PBH PRESTIGE CONSUMER HEALTHCARE INC. 0.51%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 56.5% aligned
VWAPPrice below VWAP ($109.36)
VolumeRelative volume 3.4× the 20-day average
Momentum10-day rate of change -1.9%

iShares U.S. Pharmaceuticals ETF (IHE) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Market & analysts
Momentum (10d)
-1.9%
rate of change
SMC grade
B · 66
56.5% aligned
B · 66
SMC grade — 56.5% timeframe alignment
-1.9%
Rate of change (10d)

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for IHE — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding IHE
InvestorFirmPositionWeightAs of
Ken Fisher Fisher Asset Management $272M 0.1% 2026-09-30
Ken Griffin Citadel Advisors $6M 0.0% 2026-09-30
Israel Englander Millennium Management $5M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

111.08103.3595.6287.9080.172025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
106.23
S2
106.99
S1
107.70
PIVOT
108.46
R1
109.17
R2
109.93
R3
110.64

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
98.45 – 106.66
±4.0% from 102.56, made 2026-09-25 · resolves 2026-10-02
STRONG BUY
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

BUY
19 indicators
OscillatorsSTRONG SELL
0 buy · 4 neutral · 3 sell
Moving averagesSTRONG BUY
8 buy · 0 neutral · 4 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)51.90NEUTRAL
Stochastic %K (14)36.41NEUTRAL
CCI (20)11.25NEUTRAL
Williams %R (14)-63.59NEUTRAL
MACD (12,26,9)-0.12SELL
ROC (10)-1.87SELL
Momentum (10)-2.04SELL
EMA (10)108.56SELL
SMA (10)108.98SELL
EMA (20)107.22SELL
SMA (20)107.19SELL
EMA (30)106.11BUY
SMA (30)104.96BUY
EMA (50)104.67BUY
SMA (50)103.38BUY
EMA (100)101.88BUY
SMA (100)102.90BUY
EMA (200)96.07BUY
SMA (200)95.83BUY

About iShares U.S. Pharmaceuticals ETF

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Good setup, solid confluence

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 43
⏰ 4H BEARISH 36
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-1.9%
Rate of change (10d)
3.4×
Volume vs its 20-day average
1.94
MACD (BEARISH)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.